Form 4: Clorox COO Acquires 9,611 Shares via RSU Grant
Insider Transaction Report
Clorox's EVP and Chief Operating Officer, Eric H. Reynolds, acquired 9,611 shares of common stock through a Restricted Stock Unit grant.
Summary
- Eric H. Reynolds, EVP Chief Operating Officer and Director of The Clorox Company, acquired 9,611 shares of common stock.
- The acquisition occurred on September 16, 2025, at a deemed price of $124.85 per share.
- These shares were acquired as Restricted Stock Units (RSUs), which are part of executive compensation.
- Following this transaction, Mr. Reynolds beneficially owns a total of 63,832 shares of Clorox common stock.
- The RSUs will vest in four equal annual installments, with the first vesting on October 5, 2026, and subsequent vestings on October 5, 2027, 2028, and 2029.
Sentiment
Score: 7
Explanation: The acquisition of shares by a key executive, even as an RSU grant, generally indicates alignment of interests and a long-term commitment to the company's success, which is a positive signal for investors.
Positives
- The acquisition of 9,611 shares by a key executive, Eric H. Reynolds, aligns management interests with those of shareholders.
- The four-year vesting schedule for the Restricted Stock Units provides a long-term incentive for the Chief Operating Officer, encouraging sustained performance.
Negatives
- The acquisition is a grant of Restricted Stock Units as part of compensation, not an open market purchase by the executive using personal capital.
Risks
- General market risks affecting the value of Clorox common stock.
- Company-specific operational and financial performance risks that could impact the share price.
- Potential minor dilution from the issuance of new shares upon RSU vesting.
Future Outlook
The vesting schedule for the Restricted Stock Units indicates a long-term incentive structure for the executive, aligning their interests with future company performance through October 2029.
Industry Context
This transaction is a standard executive compensation event, common across publicly traded companies to incentivize long-term performance and align management interests with shareholder value creation in the consumer goods sector.
Stakeholder Impact
- Shareholders: Potential positive impact due to increased alignment of executive interests with long-term company performance.
Next Steps
- Vesting of Restricted Stock Units in four equal annual installments on October 5, 2026, 2027, 2028, and 2029.
Key Dates
| Date | Description |
|---|---|
| 09/16/2025 | Date of RSU acquisition transaction. |
| 09/18/2025 | Date the Form 4 was signed by Attorney-in-Fact Angela Hilt. |
| 10/05/2026 | First vesting installment date for Restricted Stock Units. |
| 10/05/2027 | Second vesting installment date for Restricted Stock Units. |
| 10/05/2028 | Third vesting installment date for Restricted Stock Units. |
| 10/05/2029 | Fourth and final vesting installment date for Restricted Stock Units. |
Keywords
Clorox, CLX, Eric H. Reynolds, Form 4, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.